Tuesday, 9 August 2022

Novavax cuts 2022 revenue guidance in half, stock tanks in after-hours trading

The Maryland biotech company cut its 2022 sales outlook by about 50% and now expects to generate $2 billion to $2.3 billion in revenue.

from Earnings https://ift.tt/EYpOSo0
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)